Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-489-7 | CAS number: 13815-17-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In an in vivo guinea pig maximisation test (GPMT), conducted to GLP and according to OECD Test Guideline 406, tetraamminepalladium dichloride exhibited moderate skin sensitising potential (Allen, 2000).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15-16 June 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD Guideline study, to GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study conducted in 2000
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: David Hall Limited
Burton-on-Trent
Staffordshire
UK
- Age at study initiation:
- Weight at study initiation: 347-421 g
- Housing: solid-floor polypropylene cages; bedding - woodchips
- Diet (e.g. ad libitum): conventional; ad libitum
- Water (e.g. ad libitum): tap water; ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17-23
- Humidity (%): 30-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- 0.01% in distilled water - injection
10% in distilled water - topical induction
1% and 2% in distilled water - topical challenge - Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 0.01% in distilled water - injection
10% in distilled water - topical induction
1% and 2% in distilled water - topical challenge - No. of animals per dose:
- 10 (5 animals in control group)
- Details on study design:
- RANGE FINDING TESTS:
Intradermal induction: one animal each treated with 0.01, 0.05, 0.1, 0.5, 1.0 or 5% and examined for erythema at 24, 48 and 72 hr and at 7 days
Topical induction: Two guinea pigs (injected with Freund’s complete adjuvant 14 days earlier) each received applications of 5, 10, 25 and 50% of the test material under an occlusive dressing. Examined for erythema and odema at 1, 24 and 48 hr.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: One injection, followed 7 days later by topical application
- Exposure period: topical – 48 hr
- Test groups: Injection – three injections in shoulder region on each side of the mid-line as follows:
a) Freund's Complete Adjuvant plus distilled water in the ratio 1:1
b) 0.01% w/w formulation of the test material in distilled water
c) 0.01% w/w formulation of the test material in a 1:1 preparation of Freund's Complete Adjuvant plus distilled water.
- Control group: as above, but without the test material
- Site: shoulder region, on each side of the mid-line
- Frequency of applications: once
- Duration: topical – 48 hr
- Concentrations: 10%
B. CHALLENGE EXPOSURE
- No. of exposures: one
- Day(s) of challenge: 14 days after the topical induction
- Exposure period: 24 hr
- Test groups:
- Control group: treated with test substance as test group
- Site: flank
- Concentrations: 1% to left flank, 2% to right flank
- Evaluation (hr after challenge): 24 and 48 hr - Challenge controls:
- Treated as for test group
- Positive control substance(s):
- no
- Positive control results:
- No positive controls included in this study. A table giving historical positive control data for 2-mercaptobenzothiazole is included in the study report, showing between a 70-100% incidence of sensitisation in groups of ten female guinea pigs.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 2%
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Clinical observations:
- No evidence of adverse effects
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 2%. No with. + reactions: 6.0. Total no. in groups: 10.0. Clinical observations: No evidence of adverse effects.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1%
- No. with + reactions:
- 5
- Total no. in group:
- 10
- Clinical observations:
- No evidence of adverse effects
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1%. No with. + reactions: 5.0. Total no. in groups: 10.0. Clinical observations: No evidence of adverse effects.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1 and 2%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- One animal was found dead on day 14 from causes not related to the test material. No other clinical signs were evident.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 1 and 2%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: One animal was found dead on day 14 from causes not related to the test material. No other clinical signs were evident..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1 and 2%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- One animal was found dead on day 14 from causes not related to the test material. No other clinical signs were evident.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 1 and 2%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: One animal was found dead on day 14 from causes not related to the test material. No other clinical signs were evident..
- Interpretation of results:
- Category 1A (indication of significant skin sensitising potential) based on GHS criteria
- Conclusions:
- In an in vivo guinea pig maximisation test (GPMT), conducted to GLP and according to OECD Test Guideline 406, tetraamminepalladium dichloride exhibited moderate skin sensitising potential
- Executive summary:
Tetraammine palladium chloride was assessed for its contact sensitising potential in a guinea pig maximisation test (GPMT) conducted according to OECD Test Guideline 406, and to GLP.
A group of ten male animals were induced by intradermal injection of 0.1% of the test material (in distilled water), with and without Freund's Complete Adjuvant, followed 7 days later by topical exposure to 10% (in distilled water) under an occluded patch. Challenge doses of 1 and 2% (in distilled water) were applied to different sites 14 days later and the areas examined at 24 and 48 hr for erythema and oedema. A further group of five males were used as controls, receiving the same induction procedure but without the test substance, and challenged similarly to the treatment group.
Six of the ten treated animals showed evidence of sensitisation at 48 hr (erythema, grade 1 or 2); three further animals exhibited erythema at 24 hr but not at 48 hr and these reactions were therefore considered not to be due to sensitisation. Tetraamminepalladium chloride exhibited moderate skin sensitising potential in this study.
According to EU CLP criteria (EC 1272/2008), tetraamminepalladium chloride should be classifed as a skin sensitiser (category 1A).
Reference
In test group with 2% challenge dose, at 48 hr 6 animals showed erythema (grades 1 and 2) and one animal had odema (at 24 hr the totals were 9 and 4, respectively for erythema and odema. Reactions that had disappeared by 48 hr were not attributed to sensitisation).
In test group with 1% challenge dose, at 48 hr 5 animals showed erythema (grade 1) and one animal had odema (at 24 hr the totals were 9 and 1, respectively for erythema and odema. Reactions that had disappeared by 48 hr were not attributed to sensitisation).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
No relevant human sensitisation data were identified. No in vitro skin sensitisation studies were identified, or are required, as reliable in vivo studies are already available.
Tetraamminepalladium dichloride was assessed for its contact sensitising potential in a guinea pig maximisation test (GPMT) conducted according to OECD Test Guideline 406, and to GLP. A group of ten male animals were induced by intradermal injection of 0.1% of the test material (in distilled water), with and without Freund's Complete Adjuvant, followed 7 days later by topical exposure to 10% (in distilled water) under an occluded patch. Challenge doses of 1 and 2% (in distilled water) were applied to different sites 14 days later and the areas examined at 24 and 48 hr for erythema and oedema. A further group of five males were used as controls, receiving the same induction procedure but without the test substance, and challenged similarly to the treatment group. Six of the ten treated animals showed evidence of sensitisation at 48 hr (erythema, grade 1 or 2); three further animals exhibited erythema at 24 hr but not at 48 hr and these reactions were therefore considered not to be due to sensitisation. Tetraamminepalladium dichloride exhibited moderate skin sensitising potential in this study (Allen, 2000).
Justification for selection of skin sensitisation endpoint:
GLP study, conducted according to OECD guidelines, and the only skin sensitising study available.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
No respiratory tract sensitisation data are available. A new study was not conducted as no standard and validated test method is available and it is not a REACH Standard Information Requirement.
Justification for classification or non-classification
Based on the results of the available and reliable GPMT, tetraamminepalladium dichloride should be classified as a (strong) skin sensitiser (category 1A) according to EU CLP criteria (EC 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.